Does the development of new onset anaemia increase morbidity and mortality in stable ambulatory CHF patients?
In stable ambulatory CHF patients, the development of new onset anemia is associated with increased future morbidity and mortality.
In stable ambulatory CHF patients, development of NOA is frequent and can be predicted by a set of clinical variables. Decreases in Hb over time relate to future increased morbidity and mortality.
Komajda et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: